NCT01964521View on ClinicalTrials.gov

TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Diabetic Foot Ulcers
Interventions
DEVICE

Mepilex Transfer Ag

A soft silicone wound contact layer that absorbs and transfers exudate, maintains a moist wound healing environment and has antimicrobial properties.

Trial Locations (2)

NR4 7UY

The Norfolk & Norwich University Hospitals NHS foundation, Norwich

S60 2UD

The Rotherham NHS Foundation Trust, Rotherham

All Listed Sponsors
lead

Molnlycke Health Care AB

INDUSTRY

NCT01964521 - TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended | Biotech Hunter | Biotech Hunter